--

This article is grossly misinformed. The effect sizes in the modern open-label clinical trials using psilocybin for depression and cancer-related anxiety are astronomical, demonstrating huge therapeutic potential!

There’s now a massive concerted effort across Europe to confirm these clinical findings, with more studies being run in the UK, Switzerland, the Netherlands and Sweden (among others).

Psychedelics are fantastic substances that show great potential for healing the mind and understanding the nature of consciousness, so I say keep the research coming!

--

--

Evan Lewis-Healey
Evan Lewis-Healey

Written by Evan Lewis-Healey

PhD candidate at Cambridge University. Studying the cognitive neuroscience of altered states of consciousness.

No responses yet